

3 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Lingotto Innovation Fund | November 2025 | Indefinite | $400,000 | 1 |
| Lingotto Innovation Ventures Fund IFiled to raise in 2025, with no closing reported yet. | 2025 | Indefinite | $0 | 0 |
| Lingotto Alternative Investments Feeder Fund ICAV - Lingotto Innovation Feeder FundFiled to raise in 2023, with no closing reported yet. | 2023 | Indefinite | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
7 partners are named across this firm’s filings, 3 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| James AndersonNot on the current fund | Slowing | None listed | 15 |
Categories of Lingotto Innovation Ventures’s own portfolio companies, based on 14 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Cure Ventures | 1 | Medable |
| First Round Capital | 1 | Minerva BI |
| Omega Funds | 1 | Medable |
| The General Partnership | 1 |
| 1 |
| Morgan SametNot on the current fund | Slowing | Sales & marketing tech | 1 | 1 |
| Heidi Ha | Quiet | Fintech | 1 | 0 |
| Innes HardingNot on the current fund | Quiet | None listed | 0 | 0 |
| John SkellyNot on the current fund | Quiet | None listed | 0 | 0 |
| Linburgh Martin | Quiet | None listed | 0 | 0 |
| Robert Duggan | Quiet | Biotech & pharma, Digital health, Medical devices | 3 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Lingotto Innovation Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Minerva BI |
| Walden Catalyst Ventures | 1 | Medable |
A shared board seat: a company where filings name a Lingotto Innovation Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.